CME Group Inc. (CME) Coverage Initiated at Barclays PLC

Barclays PLC started coverage on shares of CME Group Inc. (NASDAQ:CME) in a research report released on Friday, Marketbeat.com reports. The firm issued an overweight rating and a $139.00 target price on the financial services provider’s stock.

CME has been the topic of a number of other reports. BidaskClub raised CME Group from a hold rating to a buy rating in a research note on Friday, August 18th. Jefferies Group LLC restated a buy rating and issued a $134.00 price objective (up from $128.00) on shares of CME Group in a report on Monday, July 17th. Royal Bank Of Canada raised their price objective on CME Group from $130.00 to $135.00 and gave the stock an outperform rating in a report on Tuesday, June 20th. Zacks Investment Research downgraded CME Group from a hold rating to a sell rating in a report on Tuesday, July 11th. Finally, UBS AG restated a buy rating and issued a $134.00 price objective (down from $136.00) on shares of CME Group in a report on Monday, June 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of Buy and a consensus price target of $132.56.

Shares of CME Group (NASDAQ CME) opened at 128.80 on Friday. The company has a 50-day moving average of $124.96 and a 200 day moving average of $121.76. The stock has a market capitalization of $43.78 billion, a price-to-earnings ratio of 26.29 and a beta of 0.72. CME Group has a one year low of $98.95 and a one year high of $129.75.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925 million for the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the company earned $1.14 EPS. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. Equities research analysts forecast that CME Group will post $4.81 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc. (CME) Coverage Initiated at Barclays PLC” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2017/09/12/cme-group-inc-cme-coverage-initiated-at-barclays-plc.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 2.05%. CME Group’s dividend payout ratio is presently 53.99%.

In other news, Chairman Terrence A. Duffy sold 21,815 shares of CME Group stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total value of $2,702,660.35. Following the completion of the transaction, the chairman now owns 110,711 shares in the company, valued at approximately $13,715,985.79. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Kathleen M. Cronin sold 8,125 shares of CME Group stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now owns 38,174 shares of the company’s stock, valued at approximately $4,861,458.90. The disclosure for this sale can be found here. Insiders have sold a total of 55,619 shares of company stock worth $6,959,604 over the last 90 days. 0.57% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the company. RMB Capital Management LLC grew its position in shares of CME Group by 3.1% in the 1st quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after acquiring an additional 3,501 shares in the last quarter. Thrivent Financial For Lutherans boosted its position in CME Group by 5.6% during the 1st quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock valued at $1,485,000 after purchasing an additional 660 shares during the period. Viking Fund Management LLC boosted its position in CME Group by 3.6% during the 2nd quarter. Viking Fund Management LLC now owns 29,000 shares of the financial services provider’s stock valued at $3,632,000 after purchasing an additional 1,000 shares during the period. Janus Capital Management LLC boosted its position in CME Group by 4.7% during the 1st quarter. Janus Capital Management LLC now owns 5,609,151 shares of the financial services provider’s stock valued at $666,367,000 after purchasing an additional 253,258 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its position in CME Group by 7.7% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,094,723 shares of the financial services provider’s stock valued at $137,103,000 after purchasing an additional 77,930 shares during the period. Institutional investors own 82.67% of the company’s stock.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply